Total Payments
$193,448
2024 Payments
$10,589
Companies
37
Transactions
601
Medicare Patients
15,788
Medicare Billing
$721,346
Payment Breakdown by Category
Other$167,147 (86.4%)
Travel$9,869 (5.1%)
Food & Beverage$8,124 (4.2%)
Consulting$7,460 (3.9%)
Research$660.00 (0.3%)
Education$188.31 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $167,147 | 94 | 86.4% |
| Travel and Lodging | $9,869 | 60 | 5.1% |
| Food and Beverage | $8,124 | 433 | 4.2% |
| Consulting Fee | $7,460 | 5 | 3.9% |
| Unspecified | $660.00 | 1 | 0.3% |
| Education | $188.31 | 8 | 0.1% |
Payments by Type
General
$192,788
600 transactions
Research
$660.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $129,510 | 258 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $30,374 | 68 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $15,013 | 17 | $0 (2023) |
| Lilly USA, LLC | $11,489 | 40 | $0 (2022) |
| Amgen Inc. | $3,413 | 40 | $0 (2024) |
| Eli Lilly and Company | $660.00 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $483.73 | 17 | $0 (2022) |
| Dexcom, Inc. | $451.50 | 35 | $0 (2024) |
| Corcept Therapeutics | $247.44 | 22 | $0 (2024) |
| Insulet Corporation | $167.31 | 14 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,589 | 48 | Novo Nordisk Inc ($10,306) |
| 2023 | $8,655 | 14 | Novo Nordisk Inc ($6,045) |
| 2022 | $31,629 | 72 | Novo Nordisk Inc ($19,347) |
| 2021 | $22,452 | 66 | Novo Nordisk Inc ($21,217) |
| 2020 | $12,279 | 42 | Novo Nordisk Inc ($12,007) |
| 2019 | $26,874 | 83 | Novo Nordisk Inc ($21,597) |
| 2018 | $31,507 | 118 | Novo Nordisk Inc ($20,383) |
| 2017 | $49,463 | 158 | Novo Nordisk Inc ($18,609) |
All Payment Transactions
601 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.60 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.28 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $16.97 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Bone Health | ||||||
| 10/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Corcept Therapeutics | Korlym (Drug) | Education | In-kind items and services | $11.29 | General |
| Category: Endocrinology | ||||||
| 09/23/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: Endocrinology | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $4.16 | General |
| Category: Endocrinology | ||||||
| 08/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $0.98 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $3.64 | General |
| Category: Endocrinology | ||||||
| 07/17/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Endocrinology | ||||||
| 06/24/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: Endocrinology | ||||||
| 06/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: Diabetes | ||||||
| 06/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, PARALLEL-ARM, DOUBLE-BLIND STUDY OF EFFICACY AND SAFETY OF DULAGLUTIDE WHEN ADDED TO SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | Eli Lilly and Company | $660.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 3,814 | 5,576 | $351,050 | $133,920 |
| 2022 | 28 | 4,017 | 8,181 | $446,631 | $179,020 |
| 2021 | 31 | 3,933 | 9,637 | $507,285 | $208,870 |
| 2020 | 27 | 4,024 | 10,367 | $535,331 | $199,537 |
Total Patients
15,788
Total Services
33,761
Medicare Billing
$721,346
Procedure Codes
116
All Medicare Procedures & Services
116 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 546 | 1,116 | $167,400 | $64,969 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 154 | $33,110 | $12,482 | 37.7% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 548 | 548 | $21,920 | $7,667 | 35.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 103 | 103 | $19,467 | $7,568 | 38.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 235 | 380 | $18,240 | $6,243 | 34.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 388 | 705 | $7,050 | $5,884 | 83.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 267 | 519 | $15,570 | $4,908 | 31.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 179 | 285 | $11,685 | $3,708 | 31.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 238 | 330 | $7,920 | $2,730 | 34.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 220 | 257 | $8,224 | $2,652 | 32.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 21 | $4,557 | $1,901 | 41.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 145 | 214 | $5,564 | $1,877 | 33.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $2,070 | $1,295 | 62.5% |
| 77092 | Interpretation of trabecular bone score (tbs) and report on fracture risk | Office | 2023 | 184 | 184 | $4,232 | $1,281 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,223 | $1,166 | 36.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 108 | 170 | $2,720 | $958.03 | 35.2% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 36 | 52 | $2,496 | $823.98 | 33.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 106 | 152 | $2,280 | $768.41 | 33.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 85 | 85 | $1,870 | $757.79 | 40.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 71 | 79 | $1,896 | $601.19 | 31.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $740.00 | $597.24 | 80.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 19 | 21 | $1,722 | $587.45 | 34.1% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 14 | 23 | $1,679 | $581.67 | 34.6% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 13 | 14 | $1,638 | $566.30 | 34.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 14 | $1,610 | $544.57 | 33.8% |
About Dr. Christopher Case, M.D
Dr. Christopher Case, M.D is a Internal Medicine healthcare provider based in Jefferson City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871552794.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Case, M.D has received a total of $193,448 in payments from pharmaceutical and medical device companies, with $10,589 received in 2024. These payments were reported across 601 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($167,147).
As a Medicare-enrolled provider, Case has provided services to 15,788 Medicare beneficiaries, totaling 33,761 services with total Medicare billing of $721,346. Data is available for 4 years (2020–2023), covering 116 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Jefferson City, MO
- Active Since 03/20/2006
- Last Updated 07/31/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1871552794
Products in Payments
- Ozempic (Drug) $32,063
- INVOKANA (Drug) $30,336
- RYBELSUS (Drug) $21,768
- Tresiba (Drug) $21,593
- Rybelsus (Drug) $18,524
- Kerendia (Drug) $15,013
- HUMULIN (Drug) $11,394
- Victoza (Drug) $8,208
- Xultophy 100/3.6 (Drug) $5,412
- Prolia (Biological) $2,293
- TRULICITY (Drug) $660.00
- Xultophy (Drug) $260.00
- Korlym (Drug) $247.44
- SOLIQUA (Drug) $246.97
- Dexcom G6 Transmitter (Medical Supply) $242.85
- Omnipod (Device) $167.31
- Vascepa (Drug) $141.99
- NATPARA (Drug) $125.00
- Repatha (Biological) $124.19
- EVENITY (Biological) $118.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Jefferson City
Dr. Alan Rauba, M.d, M.D
Internal Medicine — Payments: $921,314
Internal Medicine $921,314
Dr. Thomas Schneider, M.d, M.D
Internal Medicine — Payments: $17,202
Internal Medicine $17,202
Dr. Stephen Sides, D.o, D.O
Internal Medicine — Payments: $11,660
Internal Medicine $11,660
Lorenzo Mcknelly, D.o, D.O
Internal Medicine — Payments: $10,588
Internal Medicine $10,588
John Kirby, M.d, M.D
Internal Medicine — Payments: $7,872
Internal Medicine $7,872
Simin Ovais, Do, DO
Internal Medicine — Payments: $5,849
Internal Medicine $5,849